Results 1 to 10 of about 4,399 (136)

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature

Frontiers in Endocrinology, 2017
IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Vibhor Wadhwa, Gitanjali Bajaj
exaly   +3 more sources

Muscle tendon elongation with bovine pericardium (Tutopatch®) in patients with Graves' orbitopathy; a prospective, observational, multicentre study. [PDF]

Acta Ophthalmol
Abstract Purpose Patients with severe ocular motility restriction and/or large angle strabismus due to Graves' orbitopathy (GO) cannot be adequately addressed with conventional strabismus surgery using large muscle recessions. Muscle tendon elongation surgery, using a spacer of bovine pericardium (Tutopatch®) has emerged as a valuable alternative.
Jellema HM, Oeverhaus M, Eckstein A, Mombaerts I, Kloos RJHM, Hartong DT, Nieuwkerk P, Saeed P.   +7 more
europepmc   +2 more sources

Steroid-resistant Graves' orbitopathy: Therapeutic options [PDF]

Medicinski Glasnik Specijalne Bolnice za Bolesti Štitaste Žlezde i Bolesti Metabolizma "Zlatibor", 2023
Graves orbitopathy is the most common extrathyroidal manifestation of autoimmune hyperthyroidism, although it can rarely occur in euthyroid and hypothyroid patients.
Klet Sanja, Marković Bojan, Janić Tamara, Stojković Mirjana, Ćirić Jasmina, Nedeljković-Beleslin Biljana, Žarković Miloš   +6 more
doaj   +1 more source

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy

Frontiers in Endocrinology, 2022
BackgroundImmunosuppressive therapy of Graves’ orbitopathy (GO) is indicated during the active phase of disease. Intravenous steroids (IVGC) are effective in about 70% of patients, although unresponsiveness or relapse are observed.
Irene Campi, Guia Vannucchi, Ilaria Muller, Ilaria Muller, Ilaria Muller, Elisa Lazzaroni, Nicola Currò, Martina Dainese, Benedetta Montacchini, Danila Covelli, Claudio Guastella, Lorenzo Pignataro, Laura Fugazzola, Laura Fugazzola, Maura Arosio, Maura Arosio, Mario Salvi   +16 more
doaj   +1 more source

Orbital Signaling in Graves’ Orbitopathy

Frontiers in Endocrinology, 2021
Graves’ orbitopathy (GO) is a complex and poorly understood disease in which extensive remodeling of orbital tissue is dominated by adipogenesis and hyaluronan production.
Mohd Shazli Draman, Mohd Shazli Draman, Lei Zhang, Colin Dayan, Marian Ludgate   +4 more
doaj   +1 more source

Results after En Bloc Lateral Wall Decompression Surgery with Orbital Fat Resection in 111 Patients with Graves’ Orbitopathy

International Journal of Endocrinology, 2015
Purpose. To evaluate the effect of en bloc lateral wall decompression with additional orbital fat resection in terms of exophthalmos reduction and complications. Methods.
Nicole Fichter, Rudolf F. Guthoff
doaj   +1 more source

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

Türk Oftalmoloji Dergisi, 2017
Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients.
Tülay Şimşek, Nilgün Yıldırım, Belgin Efe, Nur Kebapçı   +3 more
doaj   +1 more source

Asymmetric Graves’ Orbitopathy

Frontiers in Endocrinology, 2020
Graves’ Orbitopathy (GO) is an autoimmune orbital disorder usually presenting as a sequala of autoimmune thyroid disease. The presence of GO is associated with increased psychological burden and, in severe cases may cause blindness.
Grigorios Panagiotou, Petros Perros
doaj   +1 more source

Inactive Graves’ orbitopathy: to treat or not to treat?

Российский офтальмологический журнал, 2023
Purpose: to evaluate the expediency and efficacy of conservative therapy of patients with inactive stages of Graves’ orbitopathy complicated by optical neuropathy. Materials and methods.
O. G. Panteleeva, F. H. Batyrbekova
doaj   +1 more source

The role of hormonal imbalance in the development of autoimmune dacryoadenitis in endocrine orbitopathy

Oftalʹmologiâ, 2014
The authors analyzed the hormonal profile of patients with Graves’ disease and endocrine orbitopathy with or without autoimmune dacryoadenitis.
V. G. Likhvantseva, T. N. Safonova, O. A. Gontyurova, E. A. Rudenko, V. A. Vygodin   +4 more
doaj   +3 more sources